tiprankstipranks
PsyBio Therapeutics (TSE:PSYB.H)
TSXV:PSYB.H
Canadian Market

PsyBio Therapeutics (PSYB.H) Income Statement

7 Followers

PsyBio Therapeutics Income Statement

Last quarter (Q2 2023), PsyBio Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, PsyBio Therapeutics's net income was $-181.99K. See PsyBio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21
Total Revenue
---
Cost of Revenue
---
Gross Profit
---
Operating Expense
$ 949.85K$ 4.74M$ 10.91M
Operating Income
$ -2.82M$ -4.74M$ -10.91M
Net Non Operating Interest Income Expense
---
Other Income Expense
$ 9.74K$ 162.76K$ 145.87K
Pretax Income
$ -2.86M$ -4.89M$ -11.02M
Tax Provision
---
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
$ -2.86M$ -4.89M$ -11.02M
Basic EPS
$ -0.03$ -0.04$ -0.10
Diluted EPS
$ -0.03$ -0.04$ -0.10
Basic Average Shares
$ 367.69M$ 111.81M-
Diluted Average Shares
$ 367.69M$ 111.81M$ 1.07B
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
$ 24.85K$ 4.74M-
Net Income From Continuing And Discontinued Operation
$ -2.86M$ -4.89M$ -11.02M
Normalized Income
$ -2.65M$ -3.59M$ -8.10M
Interest Expense
---
EBIT
$ -2.86M$ -4.89M$ -11.02M
EBITDA
$ -955.46K$ -4.73M$ -11.02M
Currency in USD

PsyBio Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis